CD274 and colorectal carcinoma: Analyses of response by PD-L1 and LAG-3 within the MSS population in part 2 of the study were exploratory and limited in sample size, and validation of these biomarkers in a larger population of patients with CRC would be valuable, in addition to evaluation of other biomarkers of interest such as tumour mutational burden and MSS status.